Pharmacogenomic implications of the differential distribution of CYP3A5 metabolic phenotypes among Latin American populations
This study shows that the distribution of CYP3A5 alleles (*1, *3, *6 and *7) and genotype-predicted CYP3A5 phenotypes vary significantly across Latin American cohorts (Brazilians and the One Thousand Genomes Admixed American superpopulation), as well as among subcohorts comprising individuals with the highest proportions of Native, European or sub-Saharan African ancestry. Differences in biogeographical ancestry across the study groups are the likely explanation for these results. The differential distribution of CYP3A5 phenotypes has major pharmacogenomic implications, affecting the proportion of individuals carrying high risk CYP3A5 phenotypes for the immunosuppressant tacrolimus and the number of patients that would need to be genotyped to prevent acute rejection in kidney transplant recipients under tacrolimus treatment.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:25 |
---|---|
Enthalten in: |
Pharmacogenomics - 25(2024), 4 vom: 27. März, Seite 187-195 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Suarez-Kurtz, Guilherme [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 27.03.2024 Date Revised 27.03.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.2217/pgs-2024-0009 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM369959264 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM369959264 | ||
003 | DE-627 | ||
005 | 20240328000240.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240320s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.2217/pgs-2024-0009 |2 doi | |
028 | 5 | 2 | |a pubmed24n1351.xml |
035 | |a (DE-627)NLM369959264 | ||
035 | |a (NLM)38506326 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Suarez-Kurtz, Guilherme |e verfasserin |4 aut | |
245 | 1 | 0 | |a Pharmacogenomic implications of the differential distribution of CYP3A5 metabolic phenotypes among Latin American populations |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 27.03.2024 | ||
500 | |a Date Revised 27.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a This study shows that the distribution of CYP3A5 alleles (*1, *3, *6 and *7) and genotype-predicted CYP3A5 phenotypes vary significantly across Latin American cohorts (Brazilians and the One Thousand Genomes Admixed American superpopulation), as well as among subcohorts comprising individuals with the highest proportions of Native, European or sub-Saharan African ancestry. Differences in biogeographical ancestry across the study groups are the likely explanation for these results. The differential distribution of CYP3A5 phenotypes has major pharmacogenomic implications, affecting the proportion of individuals carrying high risk CYP3A5 phenotypes for the immunosuppressant tacrolimus and the number of patients that would need to be genotyped to prevent acute rejection in kidney transplant recipients under tacrolimus treatment | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a CYP3A5 | |
650 | 4 | |a Latin American populations | |
650 | 4 | |a biogeographical ancestry | |
650 | 4 | |a high-risk CYP3A5 phenotypes | |
650 | 4 | |a tacrolimus | |
650 | 7 | |a Tacrolimus |2 NLM | |
650 | 7 | |a WM0HAQ4WNM |2 NLM | |
650 | 7 | |a Cytochrome P-450 CYP3A |2 NLM | |
650 | 7 | |a EC 1.14.14.1 |2 NLM | |
650 | 7 | |a Immunosuppressive Agents |2 NLM | |
650 | 7 | |a CYP3A5 protein, human |2 NLM | |
650 | 7 | |a EC 1.14.14.1 |2 NLM | |
700 | 1 | |a Struchiner, Claudio José |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Pharmacogenomics |d 2000 |g 25(2024), 4 vom: 27. März, Seite 187-195 |w (DE-627)NLM111671396 |x 1744-8042 |7 nnns |
773 | 1 | 8 | |g volume:25 |g year:2024 |g number:4 |g day:27 |g month:03 |g pages:187-195 |
856 | 4 | 0 | |u http://dx.doi.org/10.2217/pgs-2024-0009 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 25 |j 2024 |e 4 |b 27 |c 03 |h 187-195 |